Clinical Trials Logo

Hidradenitis clinical trials

View clinical trials related to Hidradenitis.

Filter by:

NCT ID: NCT04218422 Recruiting - Clinical trials for Hidradenitis Suppurativa

Battlefield Acupuncture for Pain in Hidradenitis Suppurativa

Start date: January 22, 2020
Phase: N/A
Study type: Interventional

The investigators will investigate battlefield acupuncture as a treatment for the pain of hidradenitis suppurativa.

NCT ID: NCT04115566 Recruiting - Clinical trials for Hidradenitis Suppurativa

Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository

HS PROGRESS
Start date: August 1, 2020
Phase:
Study type: Observational [Patient Registry]

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

NCT ID: NCT04099212 Recruiting - HYDRADENITIS Clinical Trials

15% TOPICAL RESORCINOL FOR HURLEY I-II HIDRADENITIS SUPPURATIVA.

Start date: May 15, 2019
Phase:
Study type: Observational

Prospective, observational cross-sectional study to evaluate the response of patients with HS I-II to monotherapy treatment of topical resorcin 15%, taking into account its safety, impact on quality of life and subclinical evolution.

NCT ID: NCT03967600 Recruiting - Clinical trials for Hidradenitis Suppurativa

Clinical and Biological Characteristics of Hidradenitis Suppurativa

Start date: July 15, 2016
Phase:
Study type: Observational [Patient Registry]

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

NCT ID: NCT03827798 Recruiting - Clinical trials for Hidradenitis Suppurativa

Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa

Start date: February 27, 2019
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to assess preliminary efficacy and safety of CFZ533, LYS006, MAS825 , LOU064 and VAY736 in patients with moderate to severe hidradenitis suppurativa and to determine if CFZ533, LYS006, MAS825, LOU064 and VAY736 have an adequate clinical profile for further clinical development.

NCT ID: NCT03661866 Recruiting - Psoriasis Clinical Trials

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC

TARGET-DERM
Start date: December 21, 2018
Phase:
Study type: Observational [Patient Registry]

TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.

NCT ID: NCT03553888 Recruiting - Clinical trials for Periodontal Diseases

Hidradenitis Suppurativa and Periodontal Diseases

HSPDA
Start date: May 7, 2018
Phase:
Study type: Observational

Hidradenitis suppurativa or Verneuil's disease (HS) is a neglected and often overlooked chronic inflammatory skin disease. Nevertheless, it is frequent (1% of the general population) and deeply affects quality of life in patients with moderate and severe forms of HS. This disease is characterized by the occurrence of deep, recurrent and painful nodules, progressing to abscess formation and suppuration. It is usually localized in the axillary, inguinal and anogenital areas. The pathogenesis of HS remains partly unknown but is probably multifactorial (inflammatory, genetic, infectious, etc.) and related to many risk factors (mostly smoking and obesity). An association can be found with other inflammatory diseases such as gastrointestinal and rheumatic diseases like Crohn's disease and spondylo-arthritis respectively. Periodontal diseases are a heterogeneous group of infectious diseases with an inflammatory component. Their clinical expression results in more or less rapid destruction of tooth supporting tissues. Without treatment, these lesions may progress ultimately to tooth exfoliation, the rate of disease progression being unevenly distributed in the population. Various epidemiological studies in France indicate that 12 to 13% of middle-aged adults have severe periodontal damage. In addition, a recent study shows that while 50% of adults in France are suffering from severe attachment loss, generalized forms are rare and about 10% of individuals seem to require special care. The bacterial factor is the main etiological factor of these diseases but their progression depends primarily on the host immune response and on modifying factors (genetic, systemic, environmental and behavioural). Some of these factors are identified such as uncontrolled diabetes, smoking, stress, etc.. Finally, it is well established that periodontal disease may also trigger the development of some systemic diseases such as diabetes. Thus, many common etiopathogenic factors between HS and periodontal diseases such as inflammatory components and tobacco are found. This is corroborated by observations collected from some patients with HS complaining of oral pain exacerbated during acute flares of HS. Hence the aim of this project is to clarify existing potential association between Hidradenitis suppurativa and periodontal diseases using a multicenter cross-sectional descriptive clinical approach. One hundred patients with HS will be included in the departments of dermatology at the University Hospital in Reims and at the Pasteur Institute in Paris. They will be compared with one hundred patients without HS recruited from "general practice" consultations in the departments of Odontology at the University Hospital in Reims and at Bretonneau Hospital in Paris. The severity of HS will be assessed with Hurley's score by the dermatologist. The periodontal status will be evaluated with clinical indices and radiographical parameters by a periodontist according to the "Armitage" classification of periodontal disease and to CDC-AA case definitions updated in 2012. Meanwhile, human saliva is a biological fluid taken to reflect the health status of an individual and is or may be used for diagnosis and prognosis of some oral cancers, some systemic diseases (type 2 diabetes, sarcoidosis, etc.) or periodontal diseases. The saliva will be collected and analysed by proteomics and metabolomics techniques in order to identify biomarkers for diagnosis and prognostic of HS associated or not to periodontal diseases. These unpublished works could demonstrate a predisposition to develop periodontal disease in a subgroup of HS patients and help to unravel new etiopathogenic mechanisms common to both diseases as well as ultimately lead to early periodontal management in order to avoid disease progression and tooth losses.

NCT ID: NCT03221621 Recruiting - Clinical trials for Hidradenitis Suppurativa

Cost-effectiveness of Adalimumab and Surgery vs Adalimumab in HS

HS-COST
Start date: July 31, 2018
Phase: Phase 4
Study type: Interventional

The primary objective of this randomized controlled clinical trial in a real life setting is to evaluate the cost-utility of limumab monotherapy compared with the combination of adalimumab and a maximum of three surgeries after two years of treatment in adult patients with moderate to severe HS.

NCT ID: NCT03203122 Recruiting - Clinical trials for Hidradenitis Suppurativa

Intense Pulsed Light Therapy for Hidrosadenitis Suppurativa

Start date: August 7, 2017
Phase: N/A
Study type: Interventional

6 monthly treatments with IPL laser in patients with Hidradenitis Suppurativa. The effect in measured on several severity scores.

NCT ID: NCT03146676 Recruiting - Clinical trials for Hidradenitis Suppurativa

The Ohio State University Dermatology Biorepository

Start date: April 19, 2017
Phase:
Study type: Observational

This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.